This tool will take you through current, open clinical trials in the UK and help you to understand which trials may be suitable for you. With any clinical trial you will need to be referred by your Health Care Specialist, always seek advice when considering clinical trials.

Further information can be found on our website under Clinical Trials and Novel Drugs or if you would like to speak to someone please call the Myeloma UK infoline on: 0800 980 3332

The Myeloma Trial Finder is intended only to provide information about clinical trials currently available in the UK. Trials included on Myeloma Trial Finder are not necessarily endorsed by Myeloma UK. Clinical trials involve inherent risks and any decision to participate, or not participate, in a clinical trial should be taken only after a careful assessment of the risks involved in it. Please speak to your haematologist if you are interested in taking part in a clinical trial. To the fullest extent permitted by law Myeloma UK excludes all liability howsoever arising (including negligence) as a consequence of, or in connection with, the use of information provided by Myeloma Trial Finder

There are currently 34 open trials. In 127 locations

What is a Clinical Trial?

Step 2: Choose a Trial

There are currently 34 open trials

Step 3: View Details

Trial Title:

Effects of an exercise programme on smouldering myeloma and MGUS


Exercise programme

Myeloma stage:

Smouldering, MGUS

Trial phase:



The aim of this study is to assess the feasibility and safety of a progressive, walking-based exercise programme for smouldering myeloma and MGUS, and to assess the impact of exercise on disease activity.



Royal United Hospital, Bath

Who can enter the study?

Who can enter the study?:

Patients with smouldering myeloma or monoclonal gammopathy of undetermined significance (MGUS).

What's involved?

What's involved?:

Patients are randomised to receive either a progressive exercise programme or usual care for 16 weeks.

The exercise programme consists of two supervised group classes per week and one session at home. The exercise programme includes cardio, strengthening and balance exercises, and stretching.

Disease activity, physical fitness and quality of life are measured throughout the study and again at 17 weeks.

The usual care control group are offered the exercise programme at the end of their participation in the study.

Clinical Information

Clinical Information
(for Medical Professionals):

Do you want to talk to someone? Call our myeloma Infoline